Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (8)

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

  2. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion

    Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218

2016

  1. FNDC5 is produced in the stomach and associated to body composition

    Scientific Reports, Vol. 6

2013

  1. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Muscle tissue as an endocrine organ: Comparative secretome profiling of slow-oxidative and fast-glycolytic rat muscle explants and its variation with exercise

    Journal of Proteomics, Vol. 75, Núm. 17, pp. 5414-5425

  2. The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin

    PLoS ONE, Vol. 7, Núm. 10